engineered dendritic cell therapy (Synthon)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameengineered dendritic cell therapy (Synthon)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSynthon Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSynthon Bv
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A